JPMorgan analyst Chris Schott downgraded Bausch Health Companies (NYSE: BHC) from Overweight to Neutral.The analyst comments "Following these news, we ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE